nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—Progesterone—uterine cancer	0.349	1	CrCtD
Drostanolone—CYP19A1—uterine cancer	0.16	1	CbGaD
Drostanolone—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0731	0.327	CbGbCtD
Drostanolone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0612	0.274	CbGbCtD
Drostanolone—SHBG—Progesterone—uterine cancer	0.0485	0.217	CbGbCtD
Drostanolone—AR—Progesterone—uterine cancer	0.0405	0.181	CbGbCtD
Drostanolone—Finasteride—Progesterone—uterine cancer	0.0373	0.157	CrCrCtD
Drostanolone—Trilostane—Progesterone—uterine cancer	0.0336	0.141	CrCrCtD
Drostanolone—Stanozolol—Progesterone—uterine cancer	0.0281	0.118	CrCrCtD
Drostanolone—Oxandrolone—Progesterone—uterine cancer	0.0228	0.0959	CrCrCtD
Drostanolone—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.0178	0.0749	CrCrCtD
Drostanolone—Medrysone—Progesterone—uterine cancer	0.0155	0.0653	CrCrCtD
Drostanolone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.013	0.0549	CrCrCtD
Drostanolone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.013	0.0549	CrCrCtD
Drostanolone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0127	0.0535	CrCrCtD
Drostanolone—Testosterone Propionate—Progesterone—uterine cancer	0.0114	0.0478	CrCrCtD
Drostanolone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0113	0.0476	CrCrCtD
Drostanolone—Methyltestosterone—Progesterone—uterine cancer	0.0111	0.0466	CrCrCtD
Drostanolone—Testosterone—Progesterone—uterine cancer	0.00985	0.0415	CrCrCtD
Drostanolone—CYP19A1—corpus luteum—uterine cancer	0.00469	0.231	CbGeAlD
Drostanolone—SHBG—semen—uterine cancer	0.00271	0.133	CbGeAlD
Drostanolone—CYP19A1—semen—uterine cancer	0.0022	0.108	CbGeAlD
Drostanolone—AR—semen—uterine cancer	0.00195	0.0956	CbGeAlD
Drostanolone—AR—oviduct—uterine cancer	0.00143	0.0701	CbGeAlD
Drostanolone—Finasteride—SRD5A2—uterine cancer	0.000778	0.473	CrCbGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.000482	0.055	CbGpPWpGaD
Drostanolone—AR—myometrium—uterine cancer	0.000457	0.0224	CbGeAlD
Drostanolone—SHBG—endometrium—uterine cancer	0.000448	0.022	CbGeAlD
Drostanolone—SHBG—uterus—uterine cancer	0.000413	0.0203	CbGeAlD
Drostanolone—AR—Coregulation of Androgen receptor activity—PAWR—uterine cancer	0.000384	0.0439	CbGpPWpGaD
Drostanolone—SHBG—female reproductive system—uterine cancer	0.000371	0.0182	CbGeAlD
Drostanolone—CYP19A1—endometrium—uterine cancer	0.000363	0.0178	CbGeAlD
Drostanolone—AR—epithelium—uterine cancer	0.000358	0.0176	CbGeAlD
Drostanolone—AR—uterine cervix—uterine cancer	0.000355	0.0175	CbGeAlD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.000348	0.0398	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.000348	0.0398	CbGpPWpGaD
Drostanolone—AR—smooth muscle tissue—uterine cancer	0.000345	0.017	CbGeAlD
Drostanolone—AR—decidua—uterine cancer	0.000339	0.0166	CbGeAlD
Drostanolone—SHBG—female gonad—uterine cancer	0.000338	0.0166	CbGeAlD
Drostanolone—SHBG—vagina—uterine cancer	0.000335	0.0165	CbGeAlD
Drostanolone—CYP19A1—uterus—uterine cancer	0.000335	0.0164	CbGeAlD
Drostanolone—AR—renal system—uterine cancer	0.000332	0.0163	CbGeAlD
Drostanolone—AR—endometrium—uterine cancer	0.000321	0.0158	CbGeAlD
Drostanolone—AR—mammalian vulva—uterine cancer	0.000311	0.0153	CbGeAlD
Drostanolone—CYP19A1—female reproductive system—uterine cancer	0.000301	0.0148	CbGeAlD
Drostanolone—AR—uterus—uterine cancer	0.000296	0.0146	CbGeAlD
Drostanolone—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.000278	0.0318	CbGpPWpGaD
Drostanolone—CYP19A1—female gonad—uterine cancer	0.000274	0.0134	CbGeAlD
Drostanolone—AR—female reproductive system—uterine cancer	0.000266	0.0131	CbGeAlD
Drostanolone—Trilostane—ESR2—uterine cancer	0.000259	0.158	CrCbGaD
Drostanolone—AR—female gonad—uterine cancer	0.000242	0.0119	CbGeAlD
Drostanolone—AR—vagina—uterine cancer	0.000241	0.0118	CbGeAlD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000208	0.0238	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000207	0.0237	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PGR—uterine cancer	0.000199	0.0228	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.000197	0.0225	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	0.000178	0.0204	CbGpPWpGaD
Drostanolone—CYP19A1—lymph node—uterine cancer	0.000176	0.00865	CbGeAlD
Drostanolone—AR—Nuclear Receptors—ESR2—uterine cancer	0.000175	0.02	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000173	0.0198	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—HRAS—uterine cancer	0.000165	0.0189	CbGpPWpGaD
Drostanolone—Trilostane—ESR1—uterine cancer	0.00016	0.0972	CrCbGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000157	0.018	CbGpPWpGaD
Drostanolone—AR—lymph node—uterine cancer	0.000156	0.00765	CbGeAlD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AKT1—uterine cancer	0.000146	0.0167	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000145	0.0166	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000139	0.0158	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000129	0.0148	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000129	0.0147	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000128	0.0146	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—ESR1—uterine cancer	0.000106	0.0121	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000105	0.012	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—uterine cancer	0.000105	0.012	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	9.87e-05	0.0113	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MSH6—uterine cancer	9.53e-05	0.0109	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—ESR1—uterine cancer	9.46e-05	0.0108	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	9.17e-05	0.0105	CbGpPWpGaD
Drostanolone—Testosterone—CYP11A1—uterine cancer	8.48e-05	0.0516	CrCbGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	8.4e-05	0.0096	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	8.2e-05	0.00937	CbGpPWpGaD
Drostanolone—Estradiol—ESR2—uterine cancer	8.17e-05	0.0497	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	8.1e-05	0.00925	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	7.79e-05	0.0089	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—MSH2—uterine cancer	7.73e-05	0.00883	CbGpPWpGaD
Drostanolone—Methyltestosterone—CYP19A1—uterine cancer	7.56e-05	0.046	CrCbGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	7.14e-05	0.00815	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	7.11e-05	0.00812	CbGpPWpGaD
Drostanolone—Progesterone—PGR—uterine cancer	6.76e-05	0.0411	CrCbGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	6.73e-05	0.00769	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	6.65e-05	0.0076	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—SMAD3—uterine cancer	6.6e-05	0.00754	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—CDKN1B—uterine cancer	6.43e-05	0.00734	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—YWHAE—uterine cancer	6.14e-05	0.00701	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—CDKN1B—uterine cancer	6.1e-05	0.00697	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	5.91e-05	0.00675	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	5.8e-05	0.00663	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—ESR2—uterine cancer	5.67e-05	0.00647	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—EP300—uterine cancer	5.65e-05	0.00645	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CDKN2A—uterine cancer	5.59e-05	0.00638	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	5.56e-05	0.00636	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—PIK3CA—uterine cancer	5.53e-05	0.00631	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	5.49e-05	0.00627	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—EP300—uterine cancer	5.35e-05	0.00612	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	5.28e-05	0.00603	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—STK11—uterine cancer	5.28e-05	0.00603	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	5.2e-05	0.00594	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	5.18e-05	0.00592	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—HRAS—uterine cancer	5.11e-05	0.00584	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	5.1e-05	0.00583	CbGpPWpGaD
Drostanolone—Estradiol—ESR1—uterine cancer	5.03e-05	0.0306	CrCbGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.94e-05	0.00564	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	4.86e-05	0.00556	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.82e-05	0.0055	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	4.68e-05	0.00534	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	4.54e-05	0.00519	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	4.51e-05	0.00516	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	4.5e-05	0.00514	CbGpPWpGaD
Drostanolone—Testosterone—CYP19A1—uterine cancer	4.39e-05	0.0267	CrCbGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.38e-05	0.005	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	4.34e-05	0.00496	CbGpPWpGaD
Drostanolone—Progesterone—ESR1—uterine cancer	4.27e-05	0.026	CrCbGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	4.08e-05	0.00466	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.92e-05	0.00448	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	3.76e-05	0.0043	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PHF1—uterine cancer	3.69e-05	0.00421	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.57e-05	0.00408	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.57e-05	0.00408	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.53e-05	0.00403	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	3.5e-05	0.004	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	3.46e-05	0.00396	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	3.46e-05	0.00395	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	3.37e-05	0.00385	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—EP300—uterine cancer	3.21e-05	0.00367	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CHD4—uterine cancer	3.14e-05	0.00358	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.07e-05	0.0035	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.03e-05	0.00347	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.92e-05	0.00334	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PGR—uterine cancer	2.72e-05	0.00311	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.64e-05	0.00302	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SUZ12—uterine cancer	2.63e-05	0.003	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	2.63e-05	0.003	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.62e-05	0.00299	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ESR2—uterine cancer	2.39e-05	0.00273	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.39e-05	0.00273	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.26e-05	0.00259	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.21e-05	0.00252	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.21e-05	0.00252	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NDUFB11—uterine cancer	2.2e-05	0.00251	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SRD5A2—uterine cancer	2.2e-05	0.00251	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.14e-05	0.00245	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.14e-05	0.00244	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.1e-05	0.0024	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.09e-05	0.00239	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	2.05e-05	0.00234	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.02e-05	0.0023	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.99e-05	0.00228	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.99e-05	0.00227	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.95e-05	0.00223	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.95e-05	0.00223	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.94e-05	0.00222	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	1.94e-05	0.00222	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.9e-05	0.00217	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.88e-05	0.00214	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.83e-05	0.00209	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.81e-05	0.00207	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	1.78e-05	0.00203	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.74e-05	0.00199	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.72e-05	0.00196	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.69e-05	0.00194	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.65e-05	0.00189	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKR1B1—uterine cancer	1.59e-05	0.00182	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—STAR—uterine cancer	1.59e-05	0.00182	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.51e-05	0.00172	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.46e-05	0.00167	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ESR1—uterine cancer	1.45e-05	0.00166	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.4e-05	0.0016	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PGR—uterine cancer	1.31e-05	0.0015	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.3e-05	0.00148	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.29e-05	0.00147	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.27e-05	0.00145	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.25e-05	0.00143	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—POLD1—uterine cancer	1.25e-05	0.00143	CbGpPWpGaD
Drostanolone—AR—Gene Expression—EZH2—uterine cancer	1.24e-05	0.00142	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.17e-05	0.00133	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ESR2—uterine cancer	1.15e-05	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.09e-05	0.00125	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.05e-05	0.0012	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—RRM2—uterine cancer	1.04e-05	0.00119	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—DCN—uterine cancer	1.01e-05	0.00115	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP11A1—uterine cancer	9.52e-06	0.00109	CbGpPWpGaD
Drostanolone—AR—Gene Expression—CDKN2B—uterine cancer	9.38e-06	0.00107	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKR1C3—uterine cancer	8.99e-06	0.00103	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SMAD3—uterine cancer	8.56e-06	0.000978	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—STK11—uterine cancer	7e-06	0.0008	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ESR1—uterine cancer	6.99e-06	0.000798	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.57e-06	0.000751	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.27e-06	0.000716	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTHFR—uterine cancer	5.26e-06	0.000601	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.64e-06	0.00053	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PTEN—uterine cancer	2.93e-06	0.000334	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—EP300—uterine cancer	2.79e-06	0.000319	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—uterine cancer	2.52e-06	0.000288	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.06e-06	0.000236	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—uterine cancer	1.69e-06	0.000193	CbGpPWpGaD
